I Have A Dream: Communicating a Vision Helps Managers Become Leaders

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-07-01-2001

CEOs are expected to be visionaries who set a bold direction for their organizations and inspire people to greatness. But leaders at other levels of the organization must also master the art of stirring up enthusiasm within their groups if they are to reach their common goals.

Articles in this issue
Overview of the Industry: A World of Opportunities
I Have A Dream: Communicating a Vision Helps Managers Become Leaders
Challenges to Diversity: Recruiting and Retaining Minorities
On the Right Path: Sales Careers in Pharma
Surviving a Merger: HBA Takes a Look
Recent Videos
Related Content
Bridging the Gap: A Large Pharma Blueprint

Bridging the Gap: A Large Pharma Blueprint

David Kamenir
May 9th 2025
Article

Five steps for organizations in bringing enterprise-level strategies to life.

Milan Kalawadia: Carving Out New Pathways

Milan Kalawadia: Carving Out New Pathways

Michael Christel
April 18th 2025
Article

Milan Kalawadia, CEO, North America, at Dr. Reddy’s Laboratories, goes inside the company’s new growth initiatives—and stretching the boundaries in healthcare exploration.

Pharmaceutical Industry Avoids Trump’s Tariffs — For Now

Pharmaceutical Industry Avoids Trump’s Tariffs — For Now

PharmExec Staff
April 4th 2025
Article

Eli Lilly CEO David Ricks to the BBC: “It feels like it'll be hard to come back from here."

Mark Frohlich: A ‘Natural’ Leader

Mark Frohlich: A ‘Natural’ Leader

Mike Hollan
March 13th 2025
Article

Immunotherapy pioneer Mark Frohlich, MD, CEO of Indapta Therapeutics, discusses the promise of harnessing natural killer cells to reshape treatment for cancer and autoimmune disease.

Elaina Shekhter, EPAM Chief Marketing & Strategy Officer.

Preparing for the C-Suite

Michael Wong
March 13th 2025
Article

A Harvard Business School Healthcare Alumni Association Q&A with Elaina Shekhter, EPAM’s Chief Marketing & Strategy Officer.

Q&A: Gain Therapeutics CEO Discusses AI-Driven Drug Discovery, Strategic Growth Plans

Q&A: Gain Therapeutics CEO Discusses AI-Driven Drug Discovery, Strategic Growth Plans

PE Staff
February 14th 2025
Article

Gene Mack, Gain Therapeutics CEO, provides a look into the future of the company and the use of physics-based artificial intelligence in the drug discovery process.